Company Search:
Advanced Search
Sponsored Links
Fate Therapeutics Inc Company Snapshot
Fate Therapeutics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fate Therapeutics Inc with three other companies in this sector in the United States: Immudyne Inc (2016 sales of $5.24 million ), BioTime, Inc. ($5.92 million of which 100% was Synthetic Solutions), and Oncobiologics Inc ($2.98 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Fate Therapeutics Inc
  Stock Performance Chart for Fate Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 7.37
(Figures in U.S. Dollars)
1 Week 5.1%   13 Weeks 31.4%  
4 Weeks 76.3%   52 Weeks 140.8%  
Fate Therapeutics Inc Key Data:
  Ticker: FATE Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 4,402,000
(Year Ending Jan 2017).
Employees: 66
  Currency: U.S. Dollars Market Cap: 375,738,482
  Fiscal Yr Ends: December Shares Outstanding: 50,982,155
  Share Type: Common Closely Held Shares: 1,094,614
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.